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Abstract: The yeast Pichia pastoris expression system was investigated for the production of human cathepsin C (CatC) recombinant
protein. The full-length CatC cDNA, corresponding to amino acids 12–475, was synthesized from interleukin-2 (IL-2) stimulated
human peripheral blood mononuclear cells and subcloned in the pGEM-T cloning vector. After confirming the DNA sequence of the
insert, the gene was cloned into the pPICZαA expression vector under the control of the methanol-inducible alcohol oxidase (AOX1)
promoter and transformed to P. pastoris X-33 cells. The expressed protein was secreted into the culture medium through the α-factor
mating signal sequence of the expression vector. Analysis of the culture supernatant revealed that the recombinant human CatC was
secreted as a 58-kDa molecule, indicating that human CatC was accumulated in the culture supernatant as proform composed of the
residual propart, the activation peptide, and the heavy and light chains. Extracellular recombinant proCatC was further activated by
cysteine endoprotease papain in vitro and its activity was confirmed by assays using a synthetic substrate.
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1. Introduction
Cathepsin C (dipeptidyl peptidase I, EC 3.4.14.1) is a
lysosomal cysteine protease belonging to the papain
superfamily (Izumya and Fruton, 1956). Besides its role
in lysosomal protein degradation (Coffey and de Duve,
1968), CatC is a key enzyme in the activation of many
serine proteinases that are capable of degrading various
extracellular matrix components and can lead to tissue
damage and chronic inflammation such as chronic
obstructive pulmonary disease and asthma (Wolters et
al., 2000; Adkinson et al., 2002; Kim and Nadel, 2004).
At the same time, related studies have demonstrated that
inhibitors of CatC could potentially be useful therapeutics
for the treatment of such diseases (Methot et al., 2007,
2008). Therefore, production of recombinant human CatC
protein in an effort to develop inhibitors of this enzyme is
highly appreciated. In addition to this importance, due to
its unique proteolytic specificity in sequential removal of
dipeptides from the amino terminus of protein substrates,
attention has also been drawn to the industrial applications
of CatC as a processing exopeptidase to use in amino acid
sequencing of proteins and removal of fusion peptides
from the N-termini of recombinant proteins (Lauritzen et
al., 1998; Pedersen et al., 1999).
The methylotrophic yeast Pichia pastoris is a very
successful microbial heterologous protein expression
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host that can be grown to high cell densities in simple
and cheap medium and is capable of secreting large
amounts of correctly folded eukaryotic recombinant
proteins in simple media (Cereghino and Cregg, 2000).
Contrary to bacterial expression systems, P. pastoris allows
posttranslational modifications such as disulfide bond
formation, glycosylation similar to eukaryotic cells, and
proteolytic maturation (Cregg et al., 1993). One of the
most important benefits of this strain as an expression
host is that it does not have papain-like cysteine proteases
in its genome. The absence of protease homologs in the
host genome majorly simplifies the purification of the
recombinant protein (Linnevers et al., 1997).
To date, a number of studies have been reported
on recombinant expression of human CatC that were
performed in insect and mammalian cell systems (Dahl
et al., 2001; Yang et al., 2011). However, these systems are
high-cost methods that require complex and expensive
media and involve cumbersome work procedures. In this
study, the expression pattern of the human CatC gene in
the yeast P. pastoris was studied for simple and effective
protein production. Its cDNA synthesis, recombinant
expression, extracellular secretion, proteolytic maturation,
and enzymatic activity are reported. It was found that the
yeast P. pastoris expression system is capable of expressing
the proform of the enzyme efficiently, which can be further
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maturated by cysteine endoprotease papain in vitro. To my
knowledge, this is the first study reporting human CatC
recombinant expression in P. pastoris.
2. Material and methods
2.1. Materials
The Pichia pastoris expression kit and TRIzol reagent were
purchased from Invitrogen. Human peripheral blood
mononuclear cells (PBMCs) were provided by Lonza. E.
coli DH5α was used for construction and propagation of
all vectors. The pGEM-T Easy vector was from Promega.
DNA restriction enzymes and RT-PCR Kit were from New
England Biolabs. Interleukin-2 (IL-2) was from Santa Cruz
Biotechnology. Papain from papaya latex and Gly-Phep-nitroanilide were purchased from Sigma. RPMI-1640
growth medium, 10% fetal bovine serum, streptomycin,
and penicillin were from GIBCO Life Technologies. All
other chemicals and reagents were of the highest purity.
2.2. CatC cDNA synthesis and pGEM-T-CatC
construction
PBMCs were cultured in RPMI-1640 growth medium
supplemented with 10% fetal bovine serum, 100 U/mL
penicillin, and 100 pg/mL streptomycin and stimulated
with IL-2 (1000 U / 2 × 106 cells/mL) to increase CatC
mRNA levels for 48 h at 37 °C under 5% CO2 (Rao et al.,
1997). After incubation, total RNA of the stimulated cells
was isolated with TRIzol reagent. Briefly, the stimulated
cells were harvested and washed twice with phosphatebuffered saline. The cells were lysed with 1 mL of TRIzol
by pipetting and incubated at room temperature for 5 min
to dissociate nucleoprotein complexes. Chloroform (0.2
mL) was then added to the lysate and mixed by stirring for
2 min. After centrifugation (at 4 °C and 12,000 × g for 15
min), the mixture separated into three phases, consisting
of a lower organic phase, an interphase, and an upper
aqueous phase. The aqueous phase was transferred to a
fresh centrifuge tube in the presence of 0.5 mL of isopropyl
alcohol and incubated at room temperature for 10 min.
Finally, total RNA was precipitated via centrifugation (at 4
°C and 12,000 × g for 10 min), washed twice with 1 mL of
75% ethanol, and dissolved in 50 µL of RNase-free water.
The reverse transcription of total RNA into cDNA
was performed using the first-strand cDNA synthesis
kit according to the manufacturer’s instructions. The
CatC-encoding region was amplified from the cDNA
pool by PCR using the following primers: forward
primer 5’-GGG CGG CCG CAT GGG TGC TGG GCC
CTC CT and reverse primer 5’-GGG CGG CCG CCC
CTA CAA TTT AGG AAT TGG TGT (NotI recognition
sequence is underlined). Primers contained NotI sites for
cloning into the P. pastoris expression vector pPICZαA.
The PCR amplification reaction consisted of an initial
denaturation step at 94 °C for 5 min, followed by 35 cycles

of denaturation at 94 °C for 30 s, annealing at 65 °C for 40
s, and extension at 72 °C for 100 s; a final extension step
of 10 min at 72 °C was added at the end of this reaction.
The PCR product was then analyzed on an agarose gel and
directly subcloned into the pGEM-T Easy cloning vector
using the TA cloning system. The nucleotide sequence
of the insert in the resulting pGEM-T-CatC vector was
confirmed by DNA sequencing using the T7 and SP6
promoter sequencing primers.
2.3. Construction and transformation of pPICZαA-CatC
expression vector
The pGEM-T-CatC cloning vector was transformed
into E. coli DH5α competent cells using the classic heat
shock method and grown overnight at 37 °C on LB plates
(1% tryptone, 0.5% yeast extract, 0.5% NaCl, and 1.5%
agar) containing 50 µg/mL ampicillin. After 24 h, white
colonies were selected and the presence of the insert was
determined by employing colony PCR. The transformed
colonies were then grown overnight at 37 °C and 200
rpm in LB medium (1% tryptone, 0.5% yeast extract,
0.5% NaCl) containing 50 µg/mL ampicillin and plasmid
purification was performed. In the resultant plasmid,
pGEM-T-CatC, the 1.4-kb NotI fragment encoding CatC
was excised from the vector, ligated into the NotI site at
the multicloning site of the pPICZαA expression vector,
and transformed into DH5α cells, and subsequently the
transformed colonies were grown overnight at 37 °C on LB
plates containing 25 µg/mL Zeocin. After 24 h, the Zeocinresistant transformants were inoculated into LB medium
containing 25 µg/mL Zeocin and grown overnight at
37 °C and 200 rpm. Upon plasmid purification from an
overnight bacterial culture, the presence of the insert was
determined by PCR amplification using CatC-specific
primers. The expression vector bearing the CatC cDNA,
pPICZαA-CatC, was then linearized with SacI to integrate
the expression cassette into the genome of P. pastoris
and electroporated into P. pastoris X-33 host cells using
standard procedures (Invitrogen). After transformation,
aliquots of 100 µL were plated on YPD plates (1% yeast
extract, 2% peptone, 2% glucose, and 2% agar) containing
100 µg/mL Zeocin and incubated for 2 days at 30 °C.
The presence of the expression cassette in the genome of
Zeocin-resistant clones was confirmed by colony PCR
using CatC-specific primers.
2.4. Expression and analysis of CatC in Pichia pastoris
The clones proven to contain recombinant human CatC
integrated into the P. pastoris genome were selected and
examined for productivity. Briefly, a single recombinant
clone was picked and grown in 25 mL of BMGY medium
(1% yeast extract, 2% peptone, 100 mM potassium
phosphate buffer, pH 6.0, 1.34% yeast nitrogen base, 4
× 10–5% biotin, and 1% glycerol supplemented with 100
µg/mL Zeocin) at 30 °C and 250 rpm until an OD600 of
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2.0–6.0 was reached. The cells of this preculture were then
collected by centrifugation (at room temperature and 4000
× g for 5 min) and used to inoculate 100 mL of BMMY
medium (same as BMGY but using 0.5% methanol instead
of glycerol) in a 1-L baffled flask to an OD600 of about 1.0.
Induction of the recombinant protein expression was
performed and maintained by daily feeding of the culture
with methanol (a final concentration of 0.5%). After 72 h,
the cells were harvested by centrifugation (at 4 °C and 4000
× g for 10 min) and the clear supernatant was concentrated
(20-fold) with ultrafiltration and then recovered as a crude
enzyme preparation. The resulting supernatant sample was
analyzed by SDS-PAGE using polyacrylamide gel (12.5%)
with a stacking gel (5%) under reducing conditions.
2.5. Proteolytic maturation and activity studies of CatC
Since P. pastoris expression systems lack papain-like
cysteine proteases in their genome, papain was used to
activate recombinant CatC to mimic the in vivo proteolytic
process. First, the concentrated P. pastoris culture
supernatant containing proCatC was loaded on a HiTrap
SP column and eluted with a 0–1 M NaCl gradient in 20
mM citric acid, pH 6.5, containing 1 mM EDTA and 5 mM
dithiothreitol to further purify the preparation. The eluted
proCatC between 0.2 and 0.3 M NaCl was then treated
with papain (20 µg/mL) to digest the CatC precursor
in a shaker for 4 h at 37 °C and 200 rpm. Residual CatC
activity was monitored in the aliquots withdrawn from
the preincubation mixture at predetermined time points.
The activities were measured in an assay buffer containing
20 mM citric acid, pH 4.5, 150 mM NaCl, 1 mM EDTA,
and 5 mM dithiothreitol using the chromogenic substrate
Gly-Phe-pNA (0.1%), which gives yellow-colored
p-nitroaniline (p-NA) upon hydrolysis, and the change
in absorbance at 405 nm (37 °C) was monitored. For
calibration, p-NA solutions of 1.0 to 50 mM were used. At
the end of incubation, proteolytic activation of CatC was
analyzed by SDS-PAGE. After activity assays, inhibition
studies with iodoacetamide were performed in the assay
buffer with increasing concentrations (0.01/0.1/1.0 mM) to
examine the inhibition of the produced enzyme. One unit
of CatC activity was expressed as the amount of enzyme
required to convert 1 µmol of substrate per minute under
optimum reaction conditions. Each result represents the
mean of three independent experiments performed in
triplicate on the same sample.
3. Results
3.1. Synthesis of CatC cDNA and construction and
transformation of pPICZαA-CatC vector
A full-length CatC cDNA, corresponding to amino acids
12–475, was synthesized from interleukin-2 stimulated
PBMCs. Since human CatC is present at low levels in
unstimulated lymphocytes, the transcription of the CatC
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gene was upregulated by IL-2 before total RNA isolation
from PBMCs. After induction of human CatC mRNA for
48 h, total RNA of the stimulated cells was isolated and
reverse transcribed into cDNA. The full-length CatC
cDNA was then successfully amplified from the cDNA
pool using CatC primers and a 1.4-kb fragment encoding
CatC was produced (Figure 1).
After gel purification, the concentrated full-length
CatC was cloned into the pGEM-T Easy cloning vector
and transformed into E. coli DH5α cells. The nucleotide
sequence of the insert in the selected transformed clones
was then determined to confirm that changes had not
occurred in the cDNA sequence using the T7 and SP6
promoter primers on a commercial basis.
After confirming the nucleotide sequence of the insert,
NotI digestion was performed to liberate the 1.4-kb CatC
cDNA from the pGEM-T-CatC vector and it was ligated
into the NotI site at the multicloning site of the pPICZαA
expression vector to construct the pPICZαA-CatC vector
(Figure 2).
The pPICZαA-CatC expression vector was then
linearized with SacI to integrate the expression cassette
into the P. pastoris genome and transformed into the strain
X-33, yielding the new strain P. pastoris X-33 pPICZαACatC-WT. Genomic integration of the expression cassette
encoding CatC was confirmed by colony PCR using CatC
primers as shown in Figure 3.
3.2. Expression and activation of recombinant human
CatC
To generate a functional protease for in vitro studies,
recombinant human cathepsin C production was
investigated in the yeast P. pastoris expression system.
Since this strain does not contain papain-like cysteine
proteases in its genome (Linnevers et al., 1997) and the
proenzyme is not capable of autoactivation (Dahl et al.,
2001), the analysis of the culture supernatant revealed that
recombinant human CatC was secreted as a proenzyme
with a mass of approximately 58 kDa, which is consistent
with the mass of proCatC previously reported (Dahl et al.,
2001) (Figure 4).
It was previously demonstrated that maturation of
proCatC with papain results in a 2000-fold increase
in activity (Lauritzen et al., 1998). On the basis of this
observation, proCatC was treated with papain to mimic
the in vivo proteolytic process and to exert its proteinase
activity. As shown in Figure 5, the inactive proCatC was
gradually converted into its active form in the medium.
SDS-PAGE analysis of the sample showed that the 58kDa proCatC band disappeared after the incubation and
new protein bands appeared with molecular masses of 25,
18, 12, and 7 kDa, which are in good agreement with the
molecular weights obtained in other studies. It has been
reported that mature CatC isolated from mammalian
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Figure 1. Amplification of 1.4-kb CatC fragment from the cDNA
pool using CatC primers.

Figure 3. Confirmation of genomic integration of expression
cassette encoding CatC by PCR using CatC primers (1–4: PCR
using genomic DNA of selected clones).

Figure 2. Map of the expression vector pPICZαA-CatC. 5’AOX1:
Alcohol oxidase 1 promoter region allows methanol-inducible
expression in P. pastoris; CatC: sequence encoding human
cathepsin C; AOX1 TT: transcription termination region; PTEF1:
TEF1 promotor; PEM7: EM7 promotor; Zeocin: Zeocin resistance
gene; CYC1 TT: transcription termination region processing
of resistance gene mRNA and pUC-ori: origin of replication
functional in E. coli.

tissues was cleaved into a heavy chain of 25 kDa (19 kDa
without glycosylation) and a light chain of 7.8 kDa, and
the molecular weights of 18 and 12 kDa correspond to
the excised propeptide (Dolenc et al., 1995; Cigic et al.,
1998). The two bands at 37 and 28 kDa, corresponding to
the intermediate polypeptides, resulted from incomplete
proteolytic maturation (Demirov et al., 1999), whereas the
21-kDa band corresponds to papain.
Both autocatalytic and papain-induced activation
levels of the wild-type proenzyme into active CatC were
monitored. According to the results, autoactivation was
very weak and showed no enzymatic activity, whereas
incubation of the precursor with papain resulted in
activation and processed the proenzyme into its active
mature form. After 4 h at 37 °C incubation, the activation
level of CatC reached 9.6 U/mg, corresponding to
approximately 23 mg of mature recombinant CatC per
liter of culture (Figure 6). This enzymatic activity toward
the studied synthetic substrate was high and comparable
with that of the results reported previously (Dahl et al.,
2001; Yang et al., 2011).
Lastly, to determine whether the produced enzyme
could be inhibited, an inhibition assay was performed after
maturation of CatC. Since CatC does not possess a specific
inhibitor, iodoacetamide was used as a general cysteine
protease inhibitor. Iodoacetamide inhibited CatC by 6.4%,
22.1%, and 52.7% for 0.01, 0.1, and 1.0 mM concentrations,
respectively, confirming that the produced active enzyme
could be used for the development of specific inhibitors.
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Figure 4. SDS-PAGE analysis of the culture supernatant.

4. Discussion
In this work, the methylotrophic yeast P. pastoris expression
system was tested for its ability to express human cysteine
proteinase CatC. Successful recombinant production of
human CatC is reported. Several expression systems were
studied in recent years for the recombinant production
of human CatC. In those previous reports, recombinant
production of CatC was described in mammalian and
baculovirus-infected insect cell systems (Dahl et al., 2001;
Yang et al., 2011). However, mammalian systems are
complicated, expensive to handle, and mostly inappropriate
for high-level expression of a functional enzyme. Although
baculovirus-infected insect cells are simpler systems as
compared to mammalian systems, their complicated
cultivation and expensive media makes large-scale
production difficult (Demain and Vaishnav, 2009). In contrast
to these systems, the yeast P. pastoris is a much cheaper
alternative that provides ease of handling in transformation,
cultivation, and upscaling of the strain (Cregg et al., 1993).
The benefits of using this strain are: 1) cells grow easily to
high cell densities, 2) the strain allows posttranslational
modifications similar to eukaryotic cells, 3) gene expression
is strictly controlled by carbon sources and induced by
methanol, 4) this protease-deficient strain can increase
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the yield of secreted recombinant protein by eliminating
undesirable proteolysis risk occurring after secretion of
the protein, and 5) the strain secretes few native proteins
into the culture medium, thereby allowing purification of
the secreted recombinant protein in a single step from the
culture medium (Linnevers et al., 1997; Cereghino and
Cregg, 2000). To date, a number of active human cathepsin
proteinases, including cathepsin K (Linnevers et al., 1997), F
(Wang et al., 1998), and V (Brömme et al., 1999), have been
expressed in P. pastoris, whereas there is no information
available on human cathepsin C so far.
CatC is an unusual cysteine protease in that it has a
very long pro-peptide of ~200 amino acids at the extension
of the N-terminus. The residual propart of this proregion
remains attached in the mature enzyme, which makes CatC
unique, whereas the internal activation peptide is excised
during maturation (Cigic and Pain, 1999). In this process,
the structure of CatC undergoes a series of transformations
from the proenzyme to the mature enzyme (Muno et al.,
1993). ProCatC is not capable of autoactivation, whereas
many cathepsins of this family such as cathepsins B, K,
L, S, F, and V possess this feature (Dahl et al., 2001). The
endoproteases that excise the CatC proregion and cleave
the catalytic region into heavy and light chains in vivo
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Figure 5. SDS-PAGE analysis of proCatC maturation by papain. Purified proCatC
was incubated with papain (20 µg/mL) at pH 6.5 and 37 °C for 4 h. The reaction
was stopped by the addition of SDS-PAGE sample buffer.

Figure 6. Time-dependent activation of CatC during maturation of proCatC
at pH 6.5, 37 °C with papain (●) or at pH 4.5, 37 °C without (■) (to examine
autoactivation). Aliquots were withdrawn from the preincubation mixture at the
indicated time points, and the activity was monitored in assay buffer containing
20 mM citric acid, pH 4.5, 150 mM NaCl, 1 mM EDTA, and 5 mM dithiothreitol
with 0.1% Gly-Phe-pNA.
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are unknown, but it has been shown that proCatC can
be efficiently activated with papain, and cathepsin L and
S (Lauritzen et al., 1998; Dahl et al., 2001). Therefore,
proCatC was treated with papain to mimic the in vivo
proteolytic process and activate the proenzyme into its
mature form, which led to active recombinant human CatC
being successfully obtained. Mature CatC reached high
specific activity (U/mg) in 4 h towards synthetic substrate
Gly-Phe-pNA and was considerably inhibited after in vitro
incubation with the general cysteine protease inhibitor
iodoacetamide, which corroborates the use of recombinant
CatC in the development of specific inhibitors against CatCrelated diseases. Furthermore, recombinant CatC could be
of potential value for industrial applications as a processing
exopeptidase to use in amino acid sequencing of proteins
and removal of fusion peptides from the amino termini of
recombinant proteins.

In conclusion, this study demonstrated for the first
time that the yeast P. pastoris is a functional heterologous
protein expression host for the production of recombinant
human CatC and may serve as a faster and cheaper
alternative to other expression systems, which might
promote future studies on the development of specific
CatC inhibitors and the use of CatC as a processing
enzyme in the pharmaceutical and biotechnology
industries.
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